Ribeiro Ramiro (CIK 2013623) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy EYPT (2,438 shares), Sell EYPT (2,437 shares), Sell EYPT (2,438 shares), Buy EYPT (2,437 shares), Sell EYPT (2,437 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 2,438 | $20,138 |
| 2026-07-02 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 2,437 | $36,555 |
| 2026-07-02 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 2,438 | $36,612 |
| 2026-07-02 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 2,437 | $20,130 |
| 2026-04-20 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 2,437 | $36,555 |
| 2026-04-20 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 2,437 | $20,130 |
| 2026-03-05 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 2,438 | $20,138 |
| 2026-03-05 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 2,438 | $43,567 |
| 2026-02-18 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 2,437 | $20,130 |
| 2026-02-18 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 2,437 | $36,555 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 29,250 | $241,605 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 42,544 | $727,502 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Buy | 19,667 | $0 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | Chief Medical Officer | Sell | 6,373 | $111,400 |
| 2025-11-12 | EyePoint Pharmaceuticals, Inc. (EYPT) | Chief Medical Officer | Sell | 2,722 | $31,602 |
Source: SEC Form 4 filings · as of 2026-07-02